ID   A549 B2M KO
AC   CVCL_C3CC
DR   cancercelllines; CVCL_C3CC
DR   Sigma-Aldrich; HLA003
DR   Wikidata; Q114310509
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Sigma-Aldrich=HLA003
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 7,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//